[Sorafenib in combination with chemotherapy as induction therapy for FLT3-ITD positive acute myeloid leukemia:nine cases report and literatures review]
Zhonghua Xue Ye Xue Za Zhi
.
2015 Mar;36(3):241-4.
doi: 10.3760/cma.j.issn.0253-2727.2015.03.016.
[Article in Chinese]
Authors
Sha Liu
1
,
Xudong Wei
1
,
Qingsong Yin
1
,
Ruihua Mi
1
,
Yanli Zhang
1
,
Ping Wang
1
,
Hao Ai
1
,
Huifang Zhao
1
,
Lijie Han
1
,
Yongping Song
1
Affiliation
1
Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China.
PMID:
25854472
PMCID:
PMC7342507
DOI:
10.3760/cma.j.issn.0253-2727.2015.03.016
No abstract available
Publication types
Case Reports
Review
MeSH terms
Humans
Leukemia, Myeloid, Acute*
Niacinamide / analogs & derivatives
Phenylurea Compounds
Sorafenib
Substances
Phenylurea Compounds
Niacinamide
Sorafenib
Grants and funding
基金项目:国家自然科学基金(81170520)